121 related articles for article (PubMed ID: 2527921)
1. The post-lepromin scar and its significance in the control of HD.
Walter J
Indian J Lepr; 1989 Jul; 61(3):379-86. PubMed ID: 2527921
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of the lepromin test--further information on the subject.
Dharmendra
Indian J Lepr; 1989 Jul; 61(3):387-90. PubMed ID: 2768886
[No Abstract] [Full Text] [Related]
3. Lymphocyte blastogenesis and lepromin reactivity in leprosy patients and their parents.
Foss NT; Pagnano PM; Bechelli LM; Simoes AL
Acta Leprol; 1990; 7(2):119-28. PubMed ID: 2220296
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy of far-advanced lepromatous leprosy patients with low-dose convit vaccine along with multidrug therapy (Calcutta trial).
Majumder V; Mukerjee A; Hajra SK; Saha B; Saha K
Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):26-36. PubMed ID: 8627110
[TBL] [Abstract][Full Text] [Related]
5. A comparative study on the Mitsuda type response to antigens of chemoautotrophic nocardioform bacteria and to standard lepromin in leprosy patients.
Chakrabarty AN; Dastidar SG; Chandra AK; Mukherjee M; Chaudhuri SK
Acta Leprol; 1999; 11(3):105-12. PubMed ID: 10544723
[TBL] [Abstract][Full Text] [Related]
6. A longitudinal study of immunologic reactivity in leprosy patients treated with immunotherapy.
Rada E; Ulrich M; Aranzazu N; Santaella C; Gallinoto M; Centeno M; Rodriguez V; Convit J
Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):552-8. PubMed ID: 7868953
[TBL] [Abstract][Full Text] [Related]
7. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
[TBL] [Abstract][Full Text] [Related]
8. A recessive major gene controls the mitsuda reaction in a region endemic for leprosy.
Ranque B; Alcais A; Thuc NV; Woynard S; Thai VH; Huong NT; Ba NN; Khoa PX; Schurr E; Abel L
J Infect Dis; 2005 Oct; 192(8):1475-82. PubMed ID: 16170767
[TBL] [Abstract][Full Text] [Related]
9. Blastogenic response with autologous plasma and Mitsuda's reaction in leprosy patients and their unaffected sibs.
Foss NT; Pagnano PM; Bechelli LM; Lima Filho EC
Acta Leprol; 1991; 7(4):335-45. PubMed ID: 1950443
[TBL] [Abstract][Full Text] [Related]
10. Reactions in borderline leprosy.
Ramu G; Desikan KV
Indian J Lepr; 2002; 74(2):115-28. PubMed ID: 12708730
[TBL] [Abstract][Full Text] [Related]
11. Anti-leprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: lepromin skin test results.
Gormus BJ; Baskin GB; Xu K; Ratterree MS; Mack PA; Bohm RP; Meyers WM; Walsh GP
Lepr Rev; 2002 Sep; 73(3):254-61. PubMed ID: 12449891
[TBL] [Abstract][Full Text] [Related]
12. Comment: Positive Mitsuda lepromin reaction in long-term treated lepromatous leprosy and tuberculoid relapse in lepromatous leprosy.
Walter J
Lepr Rev; 1991 Dec; 62(4):434-6. PubMed ID: 1845302
[No Abstract] [Full Text] [Related]
13. Granulomatous reaction to intradermal injection of lepromin (Mitsuda reaction) is linked to the human NRAMP1 gene in Vietnamese leprosy sibships.
Alcaïs A; Sanchez FO; Thuc NV; Lap VD; Oberti J; Lagrange PH; Schurr E; Abel L
J Infect Dis; 2000 Jan; 181(1):302-8. PubMed ID: 10608779
[TBL] [Abstract][Full Text] [Related]
14. Vaccination of human volunteers with heat-killed M. leprae: local responses in relation to the interpretation of the lepromin reaction.
Gill HK; Mustafa AS; Godal T
Int J Lepr Other Mycobact Dis; 1988 Mar; 56(1):36-44. PubMed ID: 3286799
[TBL] [Abstract][Full Text] [Related]
15. Immunologic defects in leprosy patients. I. Evidence of immune aberration of suppressor-T lymphocytes in lepromatous leprosy.
Makonkawkeyoon S; Kasinrerk W; Dettrairat S; Vithayasai V
Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):302-10. PubMed ID: 2142947
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy of lepromin-negative borderline leprosy patients with low-dose Convit vaccine as an adjunct to multidrug therapy; a six-year follow-up study in Calcutta.
Chaudhury S; Hajra SK; Mukerjee A; Saha B; Majumdar V; Chattapadhya D; Saha K
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):56-62. PubMed ID: 9207754
[TBL] [Abstract][Full Text] [Related]
17. Response of Mycobacterium habana vaccine in patients with lepromatous leprosy and their household contacts. A pilot clinical study.
Wakhlu A; Gaur SP; Kaushal GP; Misra A; Asthana P; Sircar AR
Lepr Rev; 2001 Jun; 72(2):179-91. PubMed ID: 11495449
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulation with corticosteroids and levamisole in leprosy as gauged by in vivo lepromin and in vitro CMI responses.
Kundu SK; Hazra SK; Chaudhuri SK; Nandy A
Indian J Lepr; 1985; 57(1):37-57. PubMed ID: 3839826
[TBL] [Abstract][Full Text] [Related]
19. Variable lepromin response to Mycobacterium leprae in resistant armadillos.
Job CK; Kirchheimer WF; Sanchez RM
Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):347-53. PubMed ID: 6685696
[TBL] [Abstract][Full Text] [Related]
20. The lepromin test in rhesus monkeys.
Baskin GB; Gormus BJ; Martin LN; Wolf RH; Watson EA; Walsh GP; Meyers WM; Binford CH
Int J Lepr Other Mycobact Dis; 1986 Sep; 54(3):427-36. PubMed ID: 3746044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
